Time to Talk SENS: Critiquing the Immutability of Human Aging

Aging is a three‐stage process: metabolism, damage, and pathology. The biochemical processes that sustain life generate toxins as an intrinsic side effect. These toxins cause damage, of which a small proportion cannot be removed by any endogenous repair process and thus accumulates. This accumulating damage ultimately drives age‐related degeneration. Interventions can be designed at all three stages. However, intervention in metabolism can only modestly postpone pathology, because production of toxins is so intrinsic a property of metabolic processes that greatly reducing that production would entail fundamental redesign of those processes. Similarly, intervention in pathology is a “losing battle” if the damage that drives it is accumulating unabated. By contrast, intervention to remove the accumulating damage would sever the link between metabolism and pathology, and so has the potential to postpone aging indefinitely. We survey the major categories of such damage and the ways in which, with current or foreseeable biotechnology, they could be reversed. Such ways exist in all cases, implying that indefinite postponement of aging—which we term “engineered negligible senescence”—may be within sight. Given the major demographic consequences if it came about, this possibility merits urgent debate.

[1]  M. Massi-Benedetti,et al.  Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  G. Reaven,et al.  Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? , 2000, Free radical biology & medicine.

[3]  J. Gordon Engineering the Human Germline , 2000, Heredity.

[4]  Leonard Hayflick,et al.  The future of ageing , 2000, Nature.

[5]  S. Melov,et al.  Extension of life-span with superoxide dismutase/catalase mimetics. , 2000, Science.

[6]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[7]  R. Aspinall,et al.  Thymic Involution in Aging , 2000, Journal of Clinical Immunology.

[8]  D. Clemmons,et al.  Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. , 2000, Endocrinology.

[9]  M. Fossel,et al.  Anti-aging medicine. 2. Efficacy and safety of hormones and antioxidants. , 2000, Geriatrics.

[10]  F. Maxfield,et al.  Effects of Incorporation of Immunoglobulin G and Complement Component C1q on Uptake and Degradation of Alzheimer's Disease Amyloid Fibrils by Microglia* , 2000, The Journal of Biological Chemistry.

[11]  J. Andersen,et al.  The real Dorian Gray mouse. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  J. Harris,et al.  Intimations of Immortality , 2000, Science.

[13]  A. Cerami,et al.  An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Czech,et al.  Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms , 2000, Progress in Neurobiology.

[15]  D. Butterfield,et al.  In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain , 2000, Neurochemistry International.

[16]  C. Svendsen,et al.  Neural Stem Cells: From Cell Biology to Cell Replacement , 2000, Cell transplantation.

[17]  R. Aspinall,et al.  Thymic atrophy in the mouse is a soluble problem of the thymic environment. , 2000, Vaccine.

[18]  R. Dean,et al.  Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. , 2000, Journal of lipid research.

[19]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[20]  M. Danon,et al.  Heterotopic neogenesis of skeletal muscle induced in the adult rat diaphragmatic peritoneum: ultrastructural and transplantation studies. , 1999, Histology and histopathology.

[21]  G. Goldspink,et al.  Using skeletal muscle as an artificial endocrine tissue. , 1999, The Journal of endocrinology.

[22]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[23]  B. Russell,et al.  Expression of insulin growth factor‐1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation , 1999, The Journal of physiology.

[24]  B. Ames,et al.  (R)‐α‐Lipoic acid‐supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  B. Ames Micronutrients prevent cancer and delay aging. , 1998, Toxicology letters.

[26]  C. Dunton,et al.  Autologous, hapten-modified vaccine as a treatment for human cancers. , 1998, Vaccine.

[27]  A. Luff Age‐associated Changes in the Innervation of Muscle Fibers and Changes in the Mechanical Properties of Motor Units , 1998, Annals of the New York Academy of Sciences.

[28]  L. Ketonen Neuroimaging of the aging brain. , 1998, Neurologic clinics.

[29]  Doris A Taylor,et al.  Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.

[30]  D. Martinez,et al.  Mortality Patterns Suggest Lack of Senescence in Hydra , 1998, Experimental Gerontology.

[31]  R Kuhn,et al.  Temporally and spatially regulated somatic mutagenesis in mice. , 1998, Nucleic acids research.

[32]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[33]  U. Brunk,et al.  Lipofuscin: Mechanisms of formation and increase with age , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[34]  Jeffrey M. Hausdorff,et al.  Rapid accumulation of genome rearrangements in liver but not in brain of old mice , 1997, Nature Genetics.

[35]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[36]  C. Remé,et al.  Lipofuscin in the retina: quantitative assay for an unprecedented autofluorescent compound (pyridinium bis-retinoid, A2-E) of ocular age pigment. , 1997, Experimental eye research.

[37]  R. Dean,et al.  3.P.159 Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells , 1997 .

[38]  J. Vaupel,et al.  Determinants of longevity: genetic, environmental and medical factors , 1996, Journal of internal medicine.

[39]  Andrzej Bartke,et al.  Dwarf mice and the ageing process , 1996, Nature.

[40]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[41]  E. Masoro The Biological Mechanism of Aging: Is It Still an Enigma? , 1996 .

[42]  A. Granholm,et al.  Systemic Administration of a Nerve Growth Factor Conjugate Reverses Age-Related Cognitive Dysfunction and Prevents Cholinergic Neuron Atrophy , 1996, The Journal of Neuroscience.

[43]  J. Bernhagen,et al.  An agent cleaving glucose-derived protein crosslinks in vitro and in vivo , 1996, Nature.

[44]  F. Gage,et al.  Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion , 1995, Neuroscience.

[45]  R. S. Sohal,et al.  A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. , 1992, Mutation research.

[46]  M R Rose,et al.  Evolution of senescence: late survival sacrificed for reproduction. , 1991, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[47]  P. Nagley,et al.  Yeast mitochondrial ATPase subunit 8, normally a mitochondrial gene product, expressed in vitro and imported back into the organelle. , 1986, The EMBO journal.

[48]  A. D. Blackett,et al.  Tissue vitamin E levels and lipofuscin accumulation with age in the mouse. , 1981, Journal of gerontology.

[49]  Y. Matsuzawa,et al.  Degradation of bis(monoacylglycero)phosphate by an acid phosphodiesterase in rat liver lysosomes. , 1979, The Journal of biological chemistry.

[50]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[51]  J. Campisi Cancer, aging and cellular senescence. , 2000, In vivo.

[52]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[53]  Gregory Stock,et al.  Engineering the human germline : an exploration of the science and ethics of altering the genes we pass to our children , 2000 .

[54]  J. Harris Essays on science and society: Intimations of immortality. , 2000, Science.

[55]  C. Wehr,et al.  (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  C. Czeisler,et al.  Circadian and sleep-dependent regulation of hormone release in humans. , 1999, Recent progress in hormone research.

[57]  M. Thorner,et al.  Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging. , 1997, Recent progress in hormone research.

[58]  R. Holliday Understanding ageing. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[59]  J. Lowe,et al.  Endosome-lysosomes, ubiquitin and neurodegeneration. , 1996, Advances in experimental medicine and biology.

[60]  L. Golovleva,et al.  Microbial bioconversion of pollutants. , 1992, Reviews of environmental contamination and toxicology.

[61]  Caleb E. Finch,et al.  Longevity, senescence, and the genome , 1990 .

[62]  D. Selkoe,et al.  Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. , 1989, Nature.